Camel-IDS NV Information

Camel-IDS is a biotech company developing targeted radionuclide therapeutic solutions against cancer. Camel-IDS was incorporated on October 14th 2014 in Brussels, Belgium to leverage a technology platform that has been developed at VUB (Vrije Universiteit Brussel). Camel-IDS is based on recombinant, small antigen-binding fragments derived from Camelidae heavy-chain-only antibodies (Camelids), coupled with a therapeutic radioisotope. Camelids are used to transport the radioisotope to selected cancer receptors on the cancer cell surface and will selectively kill cancer cells by irradiation.

Website	http://camel-ids.com
Revenue	$11.8 million
Funding	$117.8 million
Employees	9 (9 on RocketReach)
Founded	2014
Address	1 Burgemeester Etienne Demunterlaan, Bruxelles Jette, Brussels Capital 1090, BE
Phone	+32 2 479 93 60
Industry	Biotechnology, Research, Pharmaceuticals, Healthcare, Science and Engineering
Keywords	Radiopharmaceutical, Cancer Treatment, Nuclear Medicine, Targeted Therapy, Oncology, Radiotherapy, Therapeutic Solutions, Pharmaceutical, Cancer Research, Biotech, Drug Development, Molecular Imaging, Precision Medicine, Personalized Medicine, Preclinical Research, Clinical Trials, Immunotherapy
Competitors	Thales, Microchip Technology Inc., Advantech, Semtech, Digi International, Telit, Sierra Wireless, u-blox, Nordic Semiconductor, Quectel Wireless Solutions - Dedicated Supplier of M2M Wireless Modules +38 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies, NAICS Code 3254 Companies